Kardigan, Inc.

Healthcare · Biotechnology · United States

Last price 14.31 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.34B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure. It utilizes a proprietary research and development platform that integrates AI-based tools, real-world clinical data, and cardiac-specific analytics to optimize clinical study design, patient screening, and efficacy tracking. The...